Sign up
Pharma Capital
Market: AIM
52-week High/Low: 5.30p / 2.61p
Sector: Pharma & Biotech
Market Cap: 11.07M

Proteome Sciences plc is engaged in the research and development, primarily in the field of proteomics, using techniques to detect and characterize proteins in diseases for diagnostic, prognostic and therapeutic applications. The Company has research facilities in London, United Kingdom and Frankfurt, Germany. Through its ProteoSHOP toolkit, Proteome Sciences Plc provides proteomics...

Proteome Sciences plc

Interactive graph

col 3
col 4
col 5
col 6
View full PRM profile View Profile
View All

Market Reports Including PRM


© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.